The current PE ratio for Amgen stock as of Jul 25, 2024 is 47.49. This is calculated based on the current EPS of $7.04 and the stock price of $334.3 per share. The P/E ratio has grown by 95% from the past four quarters average of 24.3.
The average historical PE ratio of Amgen for the last ten years is 22.81. The current PE ratio of 47.49 is 108% above the historical average. Over the past ten years, AMGN's PE ratio was at its highest in the Dec 2017 quarter at 64.17, when the stock price was $173.9 and the EPS was $2.71. The lowest value was in the Dec 2016 quarter, when it reached 14.17 with a price of $146.21 and an EPS of $10.32.
Maximum annual increase: 352.86% in 2017
Maximum annual decrease: -76.11% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 22.93 | 6.35% |
| 2022 | 21.56 | -0.92% |
| 2021 | 21.76 | 17.37% |
| 2020 | 18.54 | -0.32% |
| 2019 | 18.6 | 21.33% |
| 2018 | 15.33 | -76.11% |
| 2017 | 64.17 | 352.86% |
| 2016 | 14.17 | -20.12% |
| 2015 | 17.74 | -24.29% |
| 2014 | 23.43 | 38.64% |
AMGN's current P/E ratio is above the 3, 5 and 10-year historical averages.
AMGN's PE ratio is lower than its peer stocks LLY and ABBV, but it is greater than JNJ's and ABT's. Amgen is presently trading at a higher PE ratio (47.49) than its peer group average of 31.39.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.55 | $386.7B |
| BIIB Biogen Inc | 26.22 | $30.73B |
| ABT Abbott Laboratories | 32.58 | $183.08B |
| AMGN Amgen Inc | 47.58 | $179.67B |
| ABBV AbbVie Inc | 54.94 | $326.97B |
| LLY ELI LILLY & Co | 117.98 | $764.72B |
| GILD Gilead Sciences Inc | 192.55 | $95.96B |
| BMY Bristol Myers Squibb Co | N/A | $102.27B |
| PFE Pfizer Inc | N/A | $174.36B |
| ILMN Illumina Inc | N/A | $19.2B |
AMGN's price to earnings ratio is 47.49 as of Jul 25, 2024.
Over the last 3 years, the average price to earnings ratio for AMGN stock is 21.9.
Over the last 5 years, the average price to earnings ratio for AMGN stock is 20.69.
In the last ten years, the Dec 2017 quarter recorded the highest quarterly PE ratio at 64.17.
The current price to earnings ratio of AMGN is 108% higher than the 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jul 25, 2024), Amgen's stock price is $334.3. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $7.04. Therefore, Amgen's P/E ratio for today is 47.49. PE RATIO(47.49) = STOCK PRICE($334.3) / TTM EPS($7.04)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.